NO2718543T3 - - Google Patents

Info

Publication number
NO2718543T3
NO2718543T3 NO12800169A NO12800169A NO2718543T3 NO 2718543 T3 NO2718543 T3 NO 2718543T3 NO 12800169 A NO12800169 A NO 12800169A NO 12800169 A NO12800169 A NO 12800169A NO 2718543 T3 NO2718543 T3 NO 2718543T3
Authority
NO
Norway
Application number
NO12800169A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2718543T3 publication Critical patent/NO2718543T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO12800169A 2014-02-04 2012-06-13 NO2718543T3 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461965584P 2014-02-04 2014-02-04

Publications (1)

Publication Number Publication Date
NO2718543T3 true NO2718543T3 (ko) 2018-01-06

Family

ID=53777338

Family Applications (1)

Application Number Title Priority Date Filing Date
NO12800169A NO2718543T3 (ko) 2014-02-04 2012-06-13

Country Status (8)

Country Link
US (1) US10167264B2 (ko)
EP (1) EP3102571B1 (ko)
JP (1) JP6257787B2 (ko)
CN (1) CN105980377B (ko)
DK (1) DK3102571T3 (ko)
ES (1) ES2667847T3 (ko)
NO (1) NO2718543T3 (ko)
WO (1) WO2015117547A1 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106554318A (zh) * 2015-09-25 2017-04-05 正大天晴药业集团股份有限公司 氘代二苯基氨基嘧啶化合物
CN106554347B (zh) * 2015-09-25 2020-10-30 浙江博生医药有限公司 Egfr激酶抑制剂及其制备方法和应用
CN105461640B (zh) * 2015-12-02 2017-11-21 芷威(上海)化学科技有限公司 一种酪氨酸激酶抑制剂的制备方法
CN106146406A (zh) * 2016-02-23 2016-11-23 深圳市塔吉瑞生物医药有限公司 一种取代的二氨基嘧啶类化合物及包含该化合物的组合物及其用途
CN107344925B (zh) * 2016-05-04 2022-11-11 正大天晴药业集团股份有限公司 氘代二苯基氨基-三氟甲基嘧啶化合物
CN107088196A (zh) * 2017-02-27 2017-08-25 王涛 一种治疗骨质疏松症的药物组合物
AU2020298444A1 (en) * 2019-06-20 2021-12-02 Board Of Regents Of The University Of Texas System Small molecule inhibitors of SRC tyrosine kinase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9908884B2 (en) * 2009-05-05 2018-03-06 Dana-Farber Cancer Institute, Inc. EGFR inhibitors and methods of treating disorders
EP2635284B1 (en) 2010-11-01 2019-12-18 Celgene CAR LLC Heterocyclic compounds and uses thereof
CA2861010A1 (en) * 2012-01-13 2013-07-18 Xiao Xu Heterocyclic compounds and uses as anticancer agents
CA2866857C (en) * 2012-03-15 2021-03-09 Celgene Avilomics Research, Inc. Salts of an epidermal growth factor receptor kinase inhibitor
KR102081042B1 (ko) * 2012-03-15 2020-02-26 셀젠 카르 엘엘씨 상피 성장 인자 수용체 키나제 억제제의 고체 형태

Also Published As

Publication number Publication date
ES2667847T3 (es) 2018-05-14
EP3102571B1 (en) 2018-04-04
US20170008856A1 (en) 2017-01-12
JP2017505319A (ja) 2017-02-16
WO2015117547A1 (en) 2015-08-13
EP3102571A4 (en) 2016-12-14
DK3102571T3 (en) 2018-05-07
CN105980377B (zh) 2018-07-03
CN105980377A (zh) 2016-09-28
JP6257787B2 (ja) 2018-01-10
US10167264B2 (en) 2019-01-01
EP3102571A1 (en) 2016-12-14

Similar Documents

Publication Publication Date Title
BR112014017635A2 (ko)
BR112014019923A2 (ko)
BR112014017614A2 (ko)
BR112014018750A2 (ko)
BR112014018862A2 (ko)
BR112014017592A2 (ko)
BR112014017625A2 (ko)
BR112014018745A2 (ko)
BR112014017607A2 (ko)
BR112013027865A2 (ko)
BR112014017634A2 (ko)
BR112014017609A2 (ko)
BR112014022790A2 (ko)
BR112014017588A2 (ko)
BR112014024756A2 (ko)
BR112014013184A8 (ko)
BR112014017618A2 (ko)
BR112014017630A2 (ko)
BR112014019416A2 (ko)
BR112014017621A2 (ko)
BR112014017627A2 (ko)
BR112014017622A2 (ko)
BR112014020594A2 (ko)
BR112014017631A2 (ko)
BR112014019682A2 (ko)